Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device, and Penumbra ENGINE brands, as well as components and accessories; neurovascular embolization coiling systems to treat patients with various sizes of aneurysms and other neurovascular lesions under the Penumbra Coil 400, POD400, PAC400, and Penumbra SMART Coil brand names; and neurovascular access systems designed to provide intracranial access for use in a range of neurovascular therapies under the Neuron, Neuron MAX, Select, BENCHMARK, BMX96, DDC, and PX SLIM brands. It also provides neurosurgical aspiration tools for the removal of tissue and fluids under the Artemis Neuro Evacuation Device brand; aspiration-based thrombectomy systems for vascular applications under the Indigo System brand; and detachable embolic coil systems for peripheral embolization under the Ruby Coil and Ruby LP brand names. In addition, the company offers microcatheter for the delivery of detachable coils and occlusion devices under the LANTERN brand; and detachable, microcatheter-deliverable occlusion devices designed primarily to occlude peripheral vessels under the POD (Penumbra Occlusion Device) brand, as well as immersive computer-based technologies and immersive therapeutics to promote health, motor function, and cognition under the Real Immersive System brand; and a complementary device for use with Ruby Coil and POD for vessel occlusion under the Packing Coil and Packing Coil LP brands. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.
Over the last 12 months, insiders at Penumbra, Inc. have bought $0 and sold $17.73M worth of Penumbra, Inc. stock.
On average, over the past 5 years, insiders at Penumbra, Inc. have bought $0 and sold $27.4M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 700 shares for transaction amount of $109,480 was made by O'Rourke Bridget (director) on 2018‑05‑25.
2024-06-03 | Sale | Roberts Johanna | EVP, Gen. Counsel & Secretary | 600 0.0016% | $188.90 | $113,339 | -0.12% | |
2024-05-20 | Sale | Elsesser Adam | CEO and President | 15,000 0.0386% | $200.98 | $3.01M | -6.01% | |
2024-05-13 | Sale | Roberts Johanna | EVP, Gen. Counsel & Secretary | 600 0.0016% | $207.41 | $124,447 | -6.92% | |
2024-04-01 | Sale | Roberts Johanna | EVP, Gen. Counsel & Secretary | 600 0.0015% | $217.07 | $130,242 | -6.77% | |
2024-04-01 | Sale | Kassing Don W. | director | 170 0.0005% | $223.18 | $37,941 | -6.77% | |
2024-03-04 | Sale | Bose Arani | director | 7,500 0.0194% | $250.20 | $1.88M | -17.47% | |
2024-03-01 | Sale | Roberts Johanna | EVP, Gen. Counsel & Secretary | 600 0.0016% | $237.68 | $142,607 | -12.93% | |
2024-03-01 | Sale | Kassing Don W. | director | 778 0.002% | $234.72 | $182,612 | -12.93% | |
2024-01-03 | Sale | Grewal Harpreet | director | 170 0.0005% | $240.82 | $40,939 | -4.05% | |
2024-01-02 | Sale | Sarna Surbhi | director | 85 0.0002% | $247.68 | $21,053 | -9.01% | |
2023-12-01 | Sale | Roberts Johanna | EVP, Gen. Counsel & Secretary | 600 0.0015% | $226.42 | $135,851 | -0.96% | |
2023-11-30 | Sale | O'Rourke Bridget | director | 150 0.0004% | $226.41 | $33,962 | +2.02% | |
2023-11-14 | Sale | Roberts Johanna | EVP, Gen. Counsel & Secretary | 600 0.0016% | $214.14 | $128,482 | +5.58% | |
2023-10-11 | Sale | Elsesser Adam | CEO and President | 9,670 0.0252% | $215.76 | $2.09M | +3.27% | |
2023-10-02 | Sale | Roberts Johanna | EVP, Gen. Counsel & Secretary | 600 0.0016% | $237.82 | $142,691 | -6.52% | |
2023-10-02 | Sale | Grewal Harpreet | director | 170 0.0004% | $240.99 | $40,968 | -6.52% | |
2023-10-02 | Sale | Sarna Surbhi | director | 85 0.0002% | $240.99 | $20,484 | -6.52% | |
2023-09-11 | Sale | Elsesser Adam | CEO and President | 9,666 0.025% | $298.76 | $2.89M | -25.10% | |
2023-09-08 | Sale | Kassing Don W. | director | 444 0.0011% | $288.66 | $128,165 | -23.26% | |
2023-09-01 | Sale | Roberts Johanna | EVP, Gen. Counsel & Secretary | 600 0.0016% | $265.11 | $159,067 | -14.64% |
Bose Arani | director | 164294 0.4732% | $174.82 | 0 | 54 | |
Roberts Johanna | EVP, Gen. Counsel & Secretary | 62888 0.1613% | $174.82 | 0 | 31 | |
Grewal Harpreet | director | 8980 0.0233% | $174.82 | 0 | 22 | |
O'Rourke Bridget | director | 4214 0.0109% | $174.82 | 1 | 23 | <0.0001% |
Sarna Surbhi | director | 2295 0.0059% | $174.82 | 0 | 12 | |
Kassing Don W. | director | 1175 0.0038% | $174.82 | 0 | 14 | |
Wilder Thomas | director | 340 0.0009% | $174.82 | 0 | 19 | |
Elsesser Adam | CEO and President | 942582 0% | $174.82 | 0 | 71 | |
Pray James Robert | President, International | 408431 1.0582% | $174.82 | 0 | 49 | |
Kosaraju Sridhar | President | 155351 0.4025% | $174.82 | 0 | 31 | |
Davis Daniel Donen | See Remarks | 57787 0.1497% | $174.82 | 0 | 30 | |
Rothman Lynn | EVP and Chief Business Officer | 32637 0.0846% | $174.82 | 0 | 42 | |
Sullivan Kevin James | director | 29449 0.0763% | $174.82 | 0 | 1 | |
Evans Robert D. | EVP, Gen. Counsel & Secretary | 15667 0.0406% | $174.82 | 1 | 35 | +44.13% |
Fidelity Investments | $1.3B | 14.98 | 5.81M | +0.28% | +$3.58M | 0.09 | |
BlackRock | $906.39M | 10.48 | 4.06M | +1.52% | +$13.59M | 0.02 | |
The Vanguard Group | $823.68M | 9.52 | 3.69M | +0.89% | +$7.27M | 0.02 | |
T. Rowe Price | $675.3M | 7.81 | 3.03M | -2.54% | -$17.58M | 0.08 | |
State Street | $268.78M | 3.11 | 1.2M | +9.37% | +$23.04M | 0.01 | |
Capital Research Global Investors | $252.39M | 2.92 | 1.13M | -57.77% | -$345.24M | 0.06 | |
Champlain Investment Partners, LLC | $242.06M | 2.8 | 1.08M | +131.8% | +$137.64M | 1.4 | |
William Blair Investment Management | $186.07M | 2.15 | 833,703 | +12.17% | +$20.19M | 0.48 | |
ClearBridge Investments | $175.49M | 2.03 | 786,336 | -1.81% | -$3.23M | 0.14 | |
RTW Investments, LP | $150.84M | 1.74 | 675,888 | +2% | +$2.95M | 2.23 | |
Baillie Gifford Co | $141.57M | 1.64 | 634,319 | -2.1% | -$3.04M | 0.11 | |
Geode Capital Management | $137.47M | 1.59 | 615,849 | +4.04% | +$5.33M | 0.01 | |
Capital World Investors | $121.25M | 1.4 | 543,274 | 0% | +$0 | 0.02 | |
ROCK SPRINGS CAPITAL MANAGEMENT, LP | $112.71M | 1.3 | 505,000 | -6.05% | -$7.25M | 2.87 | |
Morgan Stanley | $86.83M | 1 | 389,056 | +6.58% | +$5.36M | 0.01 | |
HERITAGE ASSET MANAGEMENT INC | $75.12M | 0.89 | 345,551 | -1.29% | -$983,472.35 | 0.39 | |
BNY Mellon | $71.98M | 0.83 | 322,498 | -4.28% | -$3.22M | 0.01 | |
Braidwell Lp | $66.04M | 0.76 | 295,892 | +32.81% | +$16.31M | 3.72 | |
Franklin Templeton Investments | $59.29M | 0.69 | 265,666 | +17.45% | +$8.81M | 0.02 | |
Charles Schwab | $57.03M | 0.66 | 255,520 | +2.17% | +$1.21M | 0.01 | |
Janus Henderson | $56.87M | 0.66 | 254,802 | -0.98% | -$563,115.54 | 0.03 | |
Northern Trust | $53.02M | 0.61 | 237,587 | -12.63% | -$7.67M | 0.01 | |
Allspring Global Investments | $42.05M | 0.49 | 188,399 | -28.95% | -$17.13M | 0.07 | |
Bellevue Group | $40.43M | 0.47 | 181,158 | -10.78% | -$4.88M | 0.62 | |
Baird Financial Group Inc | $38.36M | 0.44 | 171,861 | New | +$38.36M | 0.08 | |
AllianceBernstein | $38.19M | 0.44 | 171,124 | +16.41% | +$5.38M | 0.01 | |
American Century Investments | $37.52M | 0.43 | 168,097 | -0.57% | -$216,038.24 | 0.02 | |
Nuveen | $36.06M | 0.42 | 161,574 | -8.34% | -$3.28M | 0.01 | |
PFM Health Sciences | $34.77M | 0.4 | 155,786 | 0% | +$0 | 0.96 | |
Artisan Partners | $31.04M | 0.36 | 139,087 | -4.88% | -$1.59M | 0.05 | |
Dimensional Fund Advisors | $29.16M | 0.34 | 130,666 | +9.96% | +$2.64M | 0.01 | |
Td Asset Management Inc | $28.97M | 0.34 | 129,786 | -4.93% | -$1.5M | 0.03 | |
Qube Research & Technologies | $28.81M | 0.33 | 129,095 | +60.15% | +$10.82M | 0.04 | |
Balyasny Asset Management Llc | $28.18M | 0.33 | 126,261 | +329.94% | +$21.62M | 0.08 | |
Polar Capital | $25.1M | 0.29 | 112,452 | -11.85% | -$3.37M | 0.14 | |
RhumbLine Advisers | $24.24M | 0.28 | 108,615 | -3.61% | -$908,563.35 | 0.02 | |
AXA | $23.55M | 0.27 | 105,535 | +8.29% | +$1.8M | 0.07 | |
The Manufacturers Life Insurance Company | $23.02M | 0.27 | 103,132 | +3.25% | +$725,558.19 | 0.02 | |
JPMorgan Chase | $22.9M | 0.27 | 102,610 | +40.56% | +$6.61M | <0.01 | |
Loomis, Sayles & Company | $21.42M | 0.25 | 95,985 | +10.63% | +$2.06M | 0.03 | |
T Rowe Price Investment Management Inc | $21.32M | 0.25 | 95,522 | +41.93% | +$6.3M | 0.01 | |
Millennium Management LLC | $21M | 0.24 | 94,116 | -22.43% | -$6.07M | 0.02 | |
Amundi | $18.67M | 0.24 | 92,505 | -17.69% | -$4.01M | 0.01 | |
Man Group Plc | $20.35M | 0.24 | 91,194 | +124.12% | +$11.27M | 0.05 | |
JENNISON ASSOCIATES LLC | $19.45M | 0.23 | 87,139 | +192.13% | +$12.79M | 0.01 | |
Goldman Sachs | $19.28M | 0.22 | 86,385 | -29.66% | -$8.13M | <0.01 | |
Soleus Capital Management, L.P. | $19.13M | 0.22 | 85,700 | +7.93% | +$1.41M | 0.18 | |
Bank of America | $17.8M | 0.21 | 79,734 | +78.5% | +$7.83M | <0.01 | |
Gotham Asset Management, LLC | $17.63M | 0.2 | 79,000 | 0% | +$0 | 2.12 | |
C Worldwide Group Holding A S | $17.18M | 0.2 | 77,000 | New | +$17.18M | 0.2 |